Zhi-ran Yang - Publications

Analysis on the efficacy and safety of chemotherapy combined with or without bevacizumab after CRS+HIPEC in patients with malignant peritoneal mesothelioma: a single-center retrospective study.

Journal: Frontiers in oncology

Published: October 28, 2025

ASO Author Reflections: Cannot Be Overlooked-Increased Natural Killer Cell Infiltration is Linked to Improved Survival in Peritoneal Mesothelioma.

Journal: Annals of surgical oncology

Published: September 03, 2025

Elevated Proportion of Tumor-Infiltrating Natural Killer Cells Predicts Improved Survival in Peritoneal Mesothelioma: A Single-Center Study of 109 Cases.

Journal: Annals of surgical oncology

Published: July 07, 2025

Clinical Significance of Tumor-Infiltrating Lymphocytes in Malignant Peritoneal Mesothelioma: A Single-Center Study of 143 Cases.

Journal: Annals of surgical oncology

Published: February 07, 2025

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.

Journal: Journal of surgical oncology

Published: August 01, 2024

Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: June 22, 2023

Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 08, 2023

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.

Journal: World journal of surgical oncology

Published: September 02, 2022

Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: April 29, 2022

NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine.

Journal: World journal of surgical oncology

Published: March 08, 2022

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.

Journal: Frontiers in oncology

Published: November 09, 2021

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma.

Journal: Experimental animals

Published: January 21, 2021